Currently I serve as a CEO for BioGend Therapeutics, a regenerative medicine company focusing on bone and cartilage repair. Previously I was a R/D executive at Zimmer and Exactech. My primary interest is orthopaedic biomaterials including bioabsorbale polymers and bioceramics, and tissue engineering.
